Chinese producers may be losing price edge to India, says Granules MD
This article was originally published in Scrip
Executive Summary
Chinese firms, stung by increasing costs, are fast losing their price advantage and business, especially in areas like pharmaceutical formulation intermediates (PFIs), has now begun shifting to India, according to Krishna Prasad, managing director of Granules India, an integrated Indian formulations manufacturer.